CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment

Blood. 2018 Aug 16;132(7):758-761. doi: 10.1182/blood-2018-02-835991. Epub 2018 Jun 21.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Disease-Free Survival
  • Female
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell* / drug therapy
  • Leukemia-Lymphoma, Adult T-Cell* / genetics
  • Leukemia-Lymphoma, Adult T-Cell* / mortality
  • Male
  • Middle Aged
  • Mutation*
  • Receptors, CCR4 / genetics*
  • Survival Rate

Substances

  • Antibodies, Monoclonal, Humanized
  • CCR4 protein, human
  • Receptors, CCR4
  • mogamulizumab